Antidepressants and the Placebo Effect
Open Access
- 1 January 2014
- journal article
- Published by Hogrefe Publishing Group in Zeitschrift Für Psychologie
- Vol. 222 (3), 128-134
- https://doi.org/10.1027/2151-2604/a000176
Abstract
Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack of serotonin in the brain. Indeed, their supposed effectiveness is the primary evidence for the chemical imbalance theory. But analyses of the published data and the unpublished data that were hidden by drug companies reveals that most (if not all) of the benefits are due to the placebo effect. Some antidepressants increase serotonin levels, some decrease it, and some have no effect at all on serotonin. Nevertheless, they all show the same therapeutic benefit. Even the small statistical difference between antidepressants and placebos may be an enhanced placebo effect, due to the fact that most patients and doctors in clinical trials successfully break blind. The serotonin theory is as close as any theory in the history of science to having been proved wrong. Instead of curing depression, popular antidepressants may induce a biological vulnerability making people more likely to become depressed in the future.Keywords
This publication has 29 references indexed in Scilit:
- The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyondHuman Reproduction, 2012
- Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled TrialPsychotherapy and Psychosomatics, 2012
- Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than GoodFrontiers in Psychology, 2012
- Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive DisorderAnnals of Internal Medicine, 2011
- Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel SyndromePLOS ONE, 2010
- Antidepressant Drug Effects and Depression SeverityPublished by American Medical Association (AMA) ,2010
- Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression.Journal of Consulting and Clinical Psychology, 2008
- Changes in Brain Function (Quantitative EEG Cordance) During Placebo Lead-In and Treatment Outcomes in Clinical Trials for Major DepressionAmerican Journal of Psychiatry, 2006
- The emperor's new drugs: Effect size and moderation effects.Prevention & Treatment, 2002
- Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 MonthsPsychosomatic Medicine, 2000